30.06.2014 Views

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

DRUGS ACTING ON THE AUTONOMIC NERVOUS SYSTEM AND THEIR CLINICAL APPLICATION<br />

reactions to bites and stings. It also relaxes bronchial<br />

smooth muscle, as well as reducing blood flow and<br />

hence congestion in the lungs.<br />

The reduced blood flow to mucous membranes is also<br />

exploited to relieve the symptoms of allergic rhinitis.<br />

Ephedrine and pseudoephedrine have similar but weaker<br />

vasoconstrictive actions and are often used for this<br />

purpose.<br />

Vasoconstrictor actions are also the reason why<br />

adrenaline (epinephrine) is often coadministered with<br />

local anesthetics when these are given by injection. Here<br />

adrenaline (epinephrine) functions both to prolong the<br />

action of the local anesthetic and to prevent the escape<br />

of high concentrations into the systemic circulation with<br />

the attendant risk of causing cardiac arrhythmia.<br />

Very occasionally adrenaline (epinephrine) is used in<br />

cardiovascular emergencies – acute severe hypotension<br />

and cardiac arrest. It may be useful in the short term<br />

but it often masks the progress of the underlying problem<br />

and should be used cautiously. It is also proarrhythmogenic<br />

and increases the workload of the heart so other<br />

catecholamines such as dopamine and dobutamine are<br />

usually preferred (see Chapter 17).<br />

No approved veterinary formulations are available in<br />

the USA or UK.<br />

Formulations and dose rates<br />

Adrenaline (epinephrine) is available in an injectable formulation as<br />

0.1 mg/mL (1:10000) and 1 mg/mL (1:1000) solutions.<br />

DOGS AND CATS<br />

• Cardiac resuscitation: 0.05–0.5 mg (0.5–5 mL) of 1:10000<br />

solution intratracheally, IV or intracardially<br />

• Anaphylaxis: 0.02 mg/kg IV. Dose may be doubled and given<br />

intratracheally<br />

– Dilute 1 mL of 1:1000 solution in 10 mL saline and give<br />

1 mL/5 kg IV or IM. May repeat q.5–15 min<br />

• Feline asthma: 0.1 mL of 1:1000 solution SC or IV<br />

– Dilute 1 mL of 1:1000 solution in 10 mL saline and give<br />

1 mL/10 kg IV or IM. May repeat q.5–15 min<br />

Pharmacokinetics<br />

Adrenaline (epinephrine) is well absorbed from IM and<br />

SC sites; absorption can be enhanced by massaging the<br />

injection site and absorption is slightly faster from IM<br />

sites compared to SC. Onset of action after IV administration<br />

is immediate and after SC administration<br />

within 5–10 min. Oral administration is not effective as<br />

it is rapidly metabolized in the gut. Adrenaline (epinephrine)<br />

crosses the placenta and enters milk but does not<br />

cross the blood–brain barrier.<br />

Action is terminated by uptake and metabolism in sympathetic<br />

nerve endings. It is also metabolized in liver and<br />

other tissues by MAO and catechol-O-methyltransferase<br />

(COMT) to yield inactive metabolites.<br />

Adverse effects<br />

Adverse effects associated with adrenaline (epinephrine)<br />

administration include:<br />

● anxiety<br />

● tremor<br />

● excitability<br />

● vomiting<br />

● hypertension<br />

● arrhythmias.<br />

Repeated injections can cause necrosis at the injection<br />

site.<br />

Contraindications and precautions<br />

● Contraindicated in narrow angle glaucoma, during<br />

halothane anesthesia, during labor and in patients<br />

with heart disease and heart failure.<br />

● When combined with local anesthetics, it should not<br />

be administered to small body appendages as the<br />

ensuing vasoconstriction can cause tissue hypoxia,<br />

necrosis and slough.<br />

● Use with caution in patients with:<br />

– hyperthyroidism<br />

– diabetes mellitus<br />

– hypertension.<br />

Known drug interactions<br />

● In solution, adrenaline (epinephrine) hydrochloride<br />

is incompatible with aminophylline, hyaluronidase,<br />

sodium bicarbonate and warfarin sodium.<br />

● Adrenaline (epinephrine) should not be used concurrently<br />

with other sympathomimetic drugs.<br />

● Some antihistamines (e.g. diphenhydramine,<br />

chlorphenamine (chlorpheniramine)) and levothyroxine<br />

may potentiate the effects of adrenaline<br />

(epinephrine).<br />

● The concomitant use of β-blockers may potentiate<br />

hypertension and antagonize the bronchodilatory<br />

and cardiostimulatory effects of adrenaline<br />

(epinephrine).<br />

● Nitrates, α-blocking agents and diuretics may abolish<br />

or reduce the pressor effects of adrenaline<br />

(epinephrine).<br />

● Use of adrenaline (epinephrine) concurrently with<br />

drugs that sensitize the myocardium to arrhythmias<br />

(e.g. halothane, digoxin) may increase the risk of<br />

arrhythmias.<br />

● Use of oxytocin concurrently with adrenaline (epinephrine)<br />

or other sympathomimetic drugs can cause<br />

postpartum hypertension.<br />

Phenylpropanolamine<br />

<strong>Clinical</strong> applications<br />

Phenylpropanolamine is one of the mainstays of treatment<br />

of urinary incontinence in the bitch. Stimulation<br />

79

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!